Skip to main content

Does Cosentyx have a black box warning?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Oct 9, 2024.

Official Answer by Drugs.com

No, Cosentyx does not contain a Boxed Warning, also commonly called a “black box warning”. A Boxed Warning is the most serious safety drug warning issued by the U.S. Food and Drug Administration (FDA).

A Boxed Warning details important or life-threatening risks or side effects that may occur with treatment. Boxed warnings appear prominently at the top of the package insert as well as in the Patient Medication Guide.

This does not mean there are not important warnings and side effects with the use of Cosentyx (secukinumab). Important safety concerns and warnings, some of which may be serious, include:

This is not a complete listing of warnings, precaution and side effects. Discuss important safety information with your doctor before you start treatment with Cosentyx.

Learn more: Use, warnings, side effects and drug interactions with Cosentyx

Cosentyx is an immunosuppressant prescription medicine approved to treat:

Cosentyx may improve these conditions but may also lower your ability to fight infections.

This is not all the information you need to know about Cosentyx (secukinumab) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Cosentyx information, and discuss this information and any questions you have with your doctor or other health care provider.

Related questions

References
  • A Guide to Drug Safety Terms at FDA. US Food and Drug Administration (FDA). Accessed August 2, 2021 at https://www.fda.gov/media/74382/download
  • Cosentyx (secukinumab). Prescribing information / Medication Guide. Novartis. Revised May 2021. Accessed August 2, 2021 at https://www.drugs.com/pro/cosentyx.html

Read next

How does Ilumya work to treat psoriasis?

Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading

Prednisone: What are 12 Things You Should Know?

Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading

Where should you not use triamcinolone acetonide cream?

You should not use topical corticosteroids like triamcinolone acetonide cream on your face, groin, or axillae (underarm, armpit) unless directed by your doctor. Using triamcinolone in these areas may lead to unwanted side effects like acne, prominent blood vessels, skin thinning (atrophy), changes in skin color or unwanted hair growth. Continue reading

Related medical questions

Drug information

Related support groups